Oruka Therapeutics, Inc.
ORKA
$111.04
$2.922.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 166.00% | 11.38% | -10.28% | -15.02% | 2,071.85% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 204.91% | 114.79% | 457.99% | 189.68% | 153.05% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 166.42% | 12.26% | -8.76% | -13.99% | 1,873.79% |
|
|
|||||
| Total Current Assets | 166.42% | 12.26% | -8.76% | -13.99% | 1,873.79% |
| Net Property, Plant & Equipment | 19.56% | 106.06% | 104.05% | 102.37% | 125.23% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 24.27% | 0.00% | 139.53% | 139.53% | -95.63% |
| Total Assets | 218.78% | 33.77% | 23.38% | 22.98% | 1,671.33% |
|
|
|||||
| Total Accounts Payable | 70.45% | 3.30% | 20.02% | 2.94% | 80.85% |
| Total Accrued Expenses | 288.13% | 89.68% | 13.15% | 7.30% | -77.31% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.36% | 140.28% | 190.61% | 186.99% | 981.97% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | 26.08% | 618.37% |
| Total Other Current Liabilities | -- | -- | -- | 26.08% | 618.37% |
| Total Current Liabilities | 89.66% | 41.88% | 17.87% | 16.23% | -37.45% |
|
|
|||||
| Total Current Liabilities | 89.66% | 41.88% | 17.87% | 16.23% | -37.45% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.67% | 69.73% | 73.91% | 77.32% | 80.11% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 80.35% | 43.38% | 20.94% | 18.96% | -70.20% |
|
|
|||||
| Common Stock & APIC | 192.64% | 51.17% | 42.02% | 61.87% | 138,553.39% |
| Retained Earnings | -102.78% | -111.01% | -125.93% | -175.40% | -340.99% |
| Treasury Stock & Other | -6,207.41% | -7,900.00% | 1,431.71% | -- | -- |
| Total Common Equity | 226.26% | 33.72% | 23.65% | 42.55% | 1,275.64% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00% | 0.00% | 0.00% | -94.74% | 0.00% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -94.74% | 0.00% |
|
|
|||||
| Total Common Equity | 226.26% | 33.72% | 23.65% | 42.55% | 1,275.64% |
| Total Preferred Equity | 0.00% | 0.00% | 0.00% | -94.74% | 0.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 224.33% | 33.45% | 23.47% | 23.17% | 1,419.16% |
|
|
|||||